AKT1 and cancer: A combination of curcumin and dasatinib also resulted in the downregulation of the EGFR/IGF-1R/Akt axis, further providing evidence that this may be one of the primary mechanisms of inhibition by curcumin either alone or in synergistic combination with other anti-cancer agents (Nautiyal et al., 2011a).